These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 9131613)

  • 21. Selection in vitro of allosteric ribozymes.
    Roth A; Breaker RR
    Methods Mol Biol; 2004; 252():145-64. PubMed ID: 15017047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minimized hammerhead ribozymes.
    McCall MJ; Hendry P; Lockett TJ
    Methods Mol Biol; 1997; 74():151-9. PubMed ID: 9204430
    [No Abstract]   [Full Text] [Related]  

  • 23. Gene therapy. Intracellular immunization.
    Baltimore D
    Nature; 1988 Sep; 335(6189):395-6. PubMed ID: 3166513
    [No Abstract]   [Full Text] [Related]  

  • 24. Optimizing ribozymes for somatic cell gene therapy.
    Branch AD; Klotman PE
    Exp Nephrol; 1998; 6(1):78-83. PubMed ID: 9523177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acquisition of novel catalytic activity by the M1 RNA ribozyme: the cost of molecular adaptation.
    Cole KB; Dorit RL
    J Mol Biol; 1999 Oct; 292(4):931-44. PubMed ID: 10525416
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Engineering high-speed allosteric hammerhead ribozymes.
    Link KH; Guo L; Ames TD; Yen L; Mulligan RC; Breaker RR
    Biol Chem; 2007 Aug; 388(8):779-86. PubMed ID: 17655496
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RNA-interference-based silencing of mammalian gene expression.
    Conklin DS
    Chembiochem; 2003 Oct; 4(10):1033-9. PubMed ID: 14523921
    [No Abstract]   [Full Text] [Related]  

  • 28. Efficient RNA ligation by reverse-joined hairpin ribozymes and engineering of twin ribozymes consisting of conventional and reverse-joined hairpin ribozyme units.
    Ivanov SA; Vauléon S; Müller S
    FEBS J; 2005 Sep; 272(17):4464-74. PubMed ID: 16128815
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravirion targeting of a functional anti-human immunodeficiency virus ribozyme directed to pol.
    Giordano V; Jin DY; Rekosh D; Jeang KT
    Virology; 2000 Feb; 267(2):174-84. PubMed ID: 10662613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficient hammerhead ribozyme and antisense RNA targeting in a slow ribosome Escherichia coli mutant.
    Chen H; Ferbeyre G; Cedergren R
    Nat Biotechnol; 1997 May; 15(5):432-5. PubMed ID: 9131620
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gene therapy of AIDS].
    Fang H; Hou Z; Tian F
    Zhonghua Liu Xing Bing Xue Za Zhi; 1999 Jun; 20(3):178-80. PubMed ID: 10682532
    [No Abstract]   [Full Text] [Related]  

  • 32. Design of hairpin ribozymes for in vitro and cellular applications.
    Yu Q; Burke JM
    Methods Mol Biol; 1997; 74():161-9. PubMed ID: 9204431
    [No Abstract]   [Full Text] [Related]  

  • 33. Repression of hepatitis B virus X gene expression by hammerhead ribozymes.
    Kim YK; Junn E; Park I; Lee Y; Kang C; Ahn JK
    Biochem Biophys Res Commun; 1999 Apr; 257(3):759-65. PubMed ID: 10208856
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Current developments in anti-HIV/AIDS gene therapy.
    Tsygankov AY
    Curr Opin Investig Drugs; 2009 Feb; 10(2):137-49. PubMed ID: 19197791
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent knock down of HIV-1 replication by targeting HIV-1 Tat/Rev RNA sequences synergistically with catalytic RNA and DNA.
    Sood V; Unwalla H; Gupta N; Chakraborti S; Banerjea AC
    AIDS; 2007 Jan; 21(1):31-40. PubMed ID: 17148965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-efficiency gene knockdown using chimeric ribozymes in fish embryos.
    Boonanuntanasarn S; Takeuchi T; Yoshizaki G
    Biochem Biophys Res Commun; 2005 Oct; 336(2):438-43. PubMed ID: 16153606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Modern biotechnology: a new box for Pandora?].
    Tramper J
    Tijdschr Diergeneeskd; 2002 Feb; 127(4):116-9. PubMed ID: 11885330
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cloning strategies for catalytic antisense RNAs.
    Tabler M; Tsagris M
    Methods Mol Biol; 1997; 74():121-9. PubMed ID: 9204427
    [No Abstract]   [Full Text] [Related]  

  • 39. Design, targeting, and initial screening of sTRSV-derived hairpin ribozymes for optimum helix 1 length and catalytic efficiency in vitro.
    Richardson MW; Hostalek L; Dobson M; Hu J; Shippy R; Siwkowski A; Marmur JD; Khalili K; Klotman PE; Hampel A; Rappaport J
    Methods Mol Biol; 2004; 252():339-58. PubMed ID: 15017062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antisense inhibition: oligonucleotides, ribozymes, and siRNAs.
    Zhang YC; Taylor MM; Samson WK; Phillips MI
    Methods Mol Med; 2005; 106():11-34. PubMed ID: 15375310
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.